3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Lymphoma, Follicular
1
Heart Failure, Diastolic
1
Heart Failure
1
Breast Neoplasms
1
Interventions
venetoclax
1
saponin QA-21V1
1
perflutren
1
peginesatide
1
hematide
1
finerenone
1
empagliflozin
1
Thalidomide
1
Stem Cell Transplantation
1
Standard of Care
1
Specimen Handling
1
Simethicone
1
Rocuronium
1
Resistance Training
1
Quillaja Saponins
1
Protein Subunit Vaccines
1
Practice Guidelines as Topic
1
Kidney Transplantation
1
Hypothermia, Induced
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Eplerenone
1
Endurance Training
1
Dexamethasone
1
DM199
1
Citric Acid
1
Cholecalciferol
1
Breathing Exercises
1
Bortezomib
1
Blood Specimen Collection
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Renal Insufficiency, Chronic
×
Eplerenone
×
Clear all
NCT07029503
2026-02-24
SCARF-1
Karolinska Institutet
Phase 2
Recruiting
40 enrolled